PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY

项目 1:不同电子烟特性对急性肺损伤的影响

基本信息

  • 批准号:
    10259836
  • 负责人:
  • 金额:
    $ 59.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-19 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Over the past decade, use of electronic cigarettes (e-cigarettes) has been rapidly growing. Because e- cigarettes are relatively new to the market, there is little biologic data on their health effects, particularly how these health effects are affected by specific product characteristics. Experimental evidence can identify early signals of harm associated with e-cigarettes, but several important elements have been largely missing from prior studies, including (1) an assessment of pulmonary health effects after clinically relevant insults, like acute viral or bacterial infection; (2) an integrated assessment of acute pulmonary effects across cell culture, animal, and human models; and (3) a focus on specific device and e-liquid characteristics that are subject to regulation and might be modified to reduce adverse health effects. The UCSF TCORS has extensive experience studying the impact of tobacco products on acute lung injury using laboratory and human experimental models, and our preliminary data indicate that variation in e-cigarette characteristics may have a significant impact on pulmonary health. This project proposes a comprehensive assessment of the impact of varying e-cigarette characteristics on acute lung injury, combining data from cell culture, mouse models, and human subjects. The central hypothesis is that changes in e-cigarette device and liquid characteristics influence their acute pulmonary effects, both under healthy conditions and in the setting of acute respiratory infection and/or inflammation. This hypothesis will be tested via two specific aims: (1) Test how different device characteristics (applied power and metal coil components) impact the acute pulmonary effects of e-cigarettes, including susceptibility to viral or bacterial lung injury in cell culture and in mice, and to inhaled endotoxin in human subjects (e-cigarette users and dual users); and (2) Test how different e-liquid characteristics (nicotine concentration and flavorings) impact the acute pulmonary effects of e-cigarettes, including susceptibility to viral and bacterial lung injury in cell culture and in mice, and to inhaled endotoxin in human subjects (e-cigarette users and dual users). Both aims begin with a systematic evaluation of the impact of varying e-cigarette characteristics in cell culture and mouse models. This evaluation will be conducted with and without infectious and inflammatory stimuli, including viral (influenza) and bacterial (pneumococcal) infection. The e-cigarette characteristics that appear to be most important in these models will then be tested in a well-established human experimental model of lung injury, in which healthy volunteers inhale endotoxin, followed by bronchoscopy with bronchoalveolar lavage. This project contributes to the overall UCSF TCORS theme by focusing on the acute pulmonary health effects of specific e-cigarette device and e-liquid characteristics. These studies will yield important new knowledge regarding how specific e-cigarette device and e-liquid characteristics impact their potential to cause acute lung injury, both in a state of health and in the setting of acute infectious or inflammatory stimuli, which will inform regulation of product characteristics.
项目总结/摘要 在过去的十年中,电子烟(e-cigarettes)的使用一直在迅速增长。因为- 香烟是相对较新的市场,几乎没有生物数据对他们的健康影响,特别是如何 这些健康影响受特定产品特性的影响。实验证据可以早期识别 与电子烟相关的危害信号,但几个重要因素在很大程度上被遗漏了, 先前的研究,包括(1)评估临床相关损伤后的肺部健康影响,如急性 病毒或细菌感染;(2)对细胞培养,动物, 和人体模型;以及(3)关注受监管的特定设备和电子液体特性 并且可以被修改以减少不利的健康影响。UCSF TCORS拥有丰富的研究经验 使用实验室和人体实验模型研究烟草制品对急性肺损伤的影响, 初步数据表明,电子烟特性的变化可能对 肺健康该项目建议对不同电子烟的影响进行全面评估。 急性肺损伤的特征,结合来自细胞培养、小鼠模型和人类受试者的数据。的 中心假设是,电子烟装置和液体特性的变化影响其急性 在健康条件下和急性呼吸道感染情况下的肺部影响,和/或 炎症该假设将通过两个特定目标进行测试:(1)测试不同器械特性 (施加的功率和金属线圈组件)影响电子烟的急性肺部效应,包括 在细胞培养物和小鼠中对病毒或细菌肺损伤的易感性,以及在人体中对吸入内毒素的易感性 受试者(电子烟使用者和双重使用者);以及(2)测试不同的电子液体特性(尼古丁) 浓度和调味剂)影响电子烟的急性肺部效应,包括对病毒的易感性 以及在细胞培养物和小鼠中的细菌性肺损伤,以及在人类受试者(电子烟)中的吸入内毒素 用户和双重用户)。这两个目标开始与不同的电子烟的影响进行系统的评估 细胞培养和小鼠模型中的特征。本评价将在存在和不存在感染性 和炎症刺激,包括病毒(流感)和细菌(肺炎球菌)感染。电子烟 在这些模型中似乎最重要的特征将在一个完善的 肺损伤的人类实验模型,其中健康志愿者吸入内毒素,然后 支气管镜检查和支气管肺泡灌洗。该项目有助于整体UCSF TCORS主题, 专注于特定电子烟装置和电子液体特性的急性肺部健康影响。 这些研究将产生重要的新知识,关于特定的电子烟设备和电子液体如何在电子烟中产生作用。 这些特征影响其在健康状态和环境中引起急性肺损伤的可能性。 急性感染或炎症刺激,这将告知产品特性的监管。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carolyn Calfee其他文献

Carolyn Calfee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carolyn Calfee', 18)}}的其他基金

Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing
使用潜在类别分析和宏基因组测序对 ARDS、肺炎和脓毒症进行分子表型分析
  • 批准号:
    10649372
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Precision Medicine in the Acute Respiratory Distress Syndrome
急性呼吸窘迫综合征的精准医学
  • 批准号:
    10331306
  • 财政年份:
    2018
  • 资助金额:
    $ 59.57万
  • 项目类别:
Precision Medicine in the Acute Respiratory Distress Syndrome
急性呼吸窘迫综合征的精准医学
  • 批准号:
    10553660
  • 财政年份:
    2018
  • 资助金额:
    $ 59.57万
  • 项目类别:
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect
项目 4:短期肺效应的量化和生物标志物
  • 批准号:
    9340086
  • 财政年份:
    2017
  • 资助金额:
    $ 59.57万
  • 项目类别:
Molecular Endotypes of ARDS: Identification, Biology, and Differential Response to Therapy
ARDS 的分子内型:鉴定、生物学和对治疗的差异反应
  • 批准号:
    9233792
  • 财政年份:
    2016
  • 资助金额:
    $ 59.57万
  • 项目类别:
ARDS Endotypes: Expanded Analysis of Clinical and Biological Phenotypes and Evolution Over Time
ARDS 内型:临床和生物学表型以及随时间演变的扩展分析
  • 批准号:
    9161405
  • 财政年份:
    2016
  • 资助金额:
    $ 59.57万
  • 项目类别:
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY
项目 1:不同电子烟特性对急性肺损伤的影响
  • 批准号:
    10468882
  • 财政年份:
    2013
  • 资助金额:
    $ 59.57万
  • 项目类别:
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340
项目 4:短期肺效应的量化和生物标志物 p302-340
  • 批准号:
    8592271
  • 财政年份:
    2013
  • 资助金额:
    $ 59.57万
  • 项目类别:
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma
严重钝伤后接触香烟烟雾和急性肺损伤
  • 批准号:
    8212616
  • 财政年份:
    2011
  • 资助金额:
    $ 59.57万
  • 项目类别:
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma
严重钝伤后接触香烟烟雾和急性肺损伤
  • 批准号:
    8392231
  • 财政年份:
    2011
  • 资助金额:
    $ 59.57万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 59.57万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了